Access. Intelligence. Excellence
OCTOBER 2016 Research Alert
|This month we added four new studies to the Best Practice Database, the research repository for Best Practices, LLC. Two of the documents are from our new research on pharmaceutical new product planning. These two studies explore key elements associated with this function's role in guiding new products through the development process, and topics include structure, roles, and timing of activities. The other two documents are from a new study on the medical information function within medical affairs and topics include compliance, resource levels and collaboration. |
The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.
|Download: Pharmaceutical New Product Planning Excellence: Structure and Roles (5433) |
With so much riding on a new product launch, pharmaceutical organizations are under pressure to deliver effective products in shorter time frames. This research identifies the structure and roles of New Product Planning (NPP) groups, detailing the strengths and weaknesses of various NPP organizational structures and how the operational characteristics of the NPP function evolves as a company matures.
||Download: Pharmaceutical New Product Planning Excellence: Market Planning and Timing of Activities (5434)|
The New Product Planning function within the pharmaceutical industry has the challenging task of guiding potential new products through the complicated and costly development process. Best Practices, LLC undertook this benchmarking study to provide a road map for the timing of key market planning activities for NPP groups.
||Download: Developing Strong Medical Information Groups: Compliance, Activities, and Resource Levels (5431)|
Considering the stringent regulations in the industry, medical affairs leaders must ensure that their medical information activities are aligned with compliance requirements. Best Practices, LLC undertook benchmarking research to explore how leading pharma and biotech companies structure and resource their medical information groups.
|Download: Developing Strong Medical Information Groups: Collaboration and Challenges (5432)|
It is critical for medical information groups to collaborate effectively with internal groups to ensure the right information is conveyed to key stakeholders. This Best Practices, LLC study identifies efficient ways for internal collaboration, requisite capabilities and challenges encountered by the function.
ACCESS AND INTELLIGENCE FOR ACHIEVING WORLD-CLASS EXCELLENCE